Associations of young onset age and genetic risk of beta cell dysfunction with glycaemic progression in individuals with type 2 diabetes

Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

Melanie J. Davies, David A. D’Alessio, Judith Fradkin et al. · Diabetes Care · 2018 · 3.5K citations · Full text

Pharmacy, Endocrinology, Pharmacotherapy +17

Glycemic Control With Diet, Sulfonylurea, Metformin, or Insulin in Patients With Type 2 Diabetes Mellitus<SUBTITLE>Progressive Requirement for Multiple Therapies (UKPDS 49)</SUBTITLE>

Robert C. Turner · JAMA · 1999 · 2.4K citations

Medicine, Endocrinology, Pharmacotherapy +12

U.K. Prospective Diabetes Study 16: Overview of 6 Years' Therapy of Type II Diabetes: A Progressive Disease

Diabetes · 1995 · 1.9K citations

Medicine, Endocrinology, Internal Medicine +17

Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis

Benjamin F. Voight, Laura J. Scott, Valgerður Steinthórsdóttir et al. · Nature Genetics · 2010 · 1.8K citations · Full text

Medicine, Bioinformatics, Endocrinology +16

Incidence Trends of Type 1 and Type 2 Diabetes among Youths, 2002–2012

Elizabeth J. Mayer‐Davis, Jean M. Lawrence, Dana Dabelea et al. · New England Journal of Medicine · 2017 · 1.5K citations · Full text

Public Health, Pediatrics, Adolescent Health +12